What You Should Know:
- GrayMatters Health (GMH), developer of non-invasive treatments based on proprietary brain biomarkers associated with mental health disorders, today announced it is expanding its U.S. footprint with additional clinics now offering Prism for PTSD™ to patients.
- Prism for PTSD is the first prescribed self-neuromodulation device, cleared by the FDA to treat post-traumatic stress disorder (PTSD) as an adjunct to standard-of-care therapies.
Expansion of Prism
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
The Role of AI in Streamlining Drug Discovery and Clinical Trials: A New Era in Pharmaceutical Innovation
In the rapidly evolving world of pharmaceuticals, artificial intelligence (AI) is emerging as a game-changer. From accelerating drug discovery to enhancing the efficiency of clinical trials, AI is revolutionizing how new medicines are brought to market. This transformation is not just limited to the research and development phases; AI is also playing a critical role in ensuring that drugs meet regulatory standards.
The AI Revolution in Drug Discovery
Drug discovery has traditionally been a
Read More
Google’s AI Model Listens to Your Cough to Detect Disease
What You Should Know:
- Google Research has unveiled a groundbreaking advancement in healthcare technology with the introduction of HeAR, a bioacoustic foundation model designed to analyze human sounds and identify potential health issues.
- By leveraging the power of AI and vast amounts of audio data, HeAR aims to revolutionize disease screening, diagnosis, and monitoring.
Google’s AI Model & Dataset
The model has been trained on a massive dataset of 300 million
Read More
Clarium Secures $10.5M for AI-Powered Hospital Supply Chain
What You Should Know:
- Clarium, Inc., a healthcare technology innovator focused on transforming hospital supply chain operations, has secured a $10.5M in strategic financing round led by General Catalyst, with participation from Kaiser Permanente Ventures, Texas Medical Center Venture Fund, Yale New Haven Health, and existing investors.
- With this new funding, Clarium plans to expand its team, deepen partnerships with leading health systems, and continue refining its
Read More
BayCare to Deploy Cadence’s Remote Patient Monitoring for Chronic Disease Management
What You Should Know:
- BayCare, a healthcare system, has announced a strategic partnership with Cadence, a chronic disease management company, to implement a comprehensive remote patient monitoring and virtual care program.
- This collaboration aims to enhance the care of seniors with chronic conditions such as hypertension, congestive heart failure, and type 2 diabetes across Florida’s Tampa Bay and West Central regions.
Proactive and Preventive Healthcare to Seniors with
Read More
Reliant AI Emerges from Stealth with $11.3M for GenAI Biopharma Data Analysis
What You Should Know:
- Reliant AI, a provider of generative AI-powered data analytics software, today announced its official launch and a significant $11.3M in seed funding round led by Tola Capital and Inovia Capital, with participation from angel investor Mike Volpi, the investment will fuel the company's growth and expansion.
- Founded by a team of leading experts in natural language processing and reinforcement learning with backgrounds at DeepMind, Google Brain, and EY
Read More
West Tennessee Healthcare Expands AI Engagement with Xsolis
What You Should Know:
- Xsolis, the AI-driven health technology company fostering collaboration between healthcare providers and payers, today announced an expansion of its partnership with West Tennessee Healthcare, a healthcare system with seven hospitals serving West Tennessee, to streamline medical necessity case reviews and reduce length of stay.
- The collaboration between Xsolis and West Tennessee Healthcare has led West Tennessee Healthcare to $5.1 million in savings since the
Read More
Combat Health Misinformation with Conversational Intelligence
The digital era presents healthcare leaders with a formidable challenge: a tidal wave of online health misinformation shaping patient behaviors and decisions. A single viral social media post can ignite widespread confusion, driving patients to pursue treatments, medications, or services that may—or may not—relate to their condition or patient journey. Healthcare organizations then scramble to manage surging call volumes, strained resources, frustrated patients, and a compromised healthcare
Read More
Accenture Invests in Earli Inc. for Early Cancer Detection
What You Should Know:
- Accenture today announced a strategic investment in Earli Inc., a biotechnology company pioneering a novel approach to early cancer detection.
- Earli’s groundbreaking technology aims to transform cancer diagnosis and treatment by enabling the rapid and accurate identification of cancerous cells.
Synthetic Targeting Platform for Early Cancer Detection
Earli has developed a synthetic targeting platform that selectively reprograms cancer cells,
Read More
Caresyntax Secures $180M to Advance Precision Surgery Platform
What You Should Know:
- Caresyntax, a leader in vendor-neutral precision surgery platforms raises $180M in funding, comprised of $80M in equity and up to $100M in growth debt, will fuel the company's continued growth and development of its AI-powered surgical platform.
- The funding round was led by a consortium of prominent investors, including Symbiotic Capital, MTIP AG, BIONIQ Capital, and BlackRock Innovation Capital. This significant investment demonstrates the growing
Read More
